Navigation Links
CareFusion Reports First Quarter Fiscal 2012 Results
Date:11/7/2011

mation to investors regarding CareFusion's financial condition and results of operations is included as Exhibit 99.3 to CareFusion's report on Form 8-K filed with the Securities and Exchange Commission on Nov. 7, 2011.

Cautions Concerning Forward-looking StatementsThe CareFusion news release and the information contained herein contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. The matters discussed in these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these uncertainties are described in CareFusion's Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those reports, and include (but are not limited to) the following: we may be unable to effectively enhance our existing products or introduce and market new products or may fail to keep pace with advances in technology; we are subject to complex and costly regulation; cost containment efforts of our customers, purchasing groups, third-party payers and governmental organizations could adversely affect our sales and profitability; current economic conditions have and may continue to adversely affect our results of operations and financial condition; we may be unable to realize any benefit from our cost reduction and restructuring efforts and our profitability may be hurt or our business otherwise might be adversely affected; we may be unable to protect our intellectual property rights or may infringe on the intellectual property rights of others; defects or failures associated with our products and/or our quality system could lead to the filing of adverse event reports, recalls or safety alerts and negative publicity and could subject us to regulatory actions; we are currently operating under an amended consent decree
'/>"/>

SOURCE CareFusion
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. ERT Closes the Acquisition of the Research Services Division of CareFusion Corporation
2. Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011
3. InterMune Reports Third Quarter 2011 Financial Results and Business Highlights
4. Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results
5. Optimer Pharmaceuticals Reports Third Quarter 2011 Financial Results
6. Caliper Life Sciences Reports Third Quarter 2011 Results
7. Neurocrine Biosciences Reports Third Quarter 2011 Results
8. United Therapeutics Corporation Reports Third Quarter 2011 Financial Results
9. Sangamo BioSciences Reports Third Quarter 2011 Financial Results
10. Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones
11. ReportsnReports: Depression Therapeutics Market to Reach $10.9 Billion by 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... CARLSBAD, Calif. , June 19, 2013 /PRNewswire/ ... soil, plant, stool and other challenging microbial nucleic ... Soil Protein Extraction Kit, for extraction of pure ... the protein world coincides with the 20 th ... ever growing innovation capabilities. (Photo: ...
(Date:6/19/2013)... 2013 Bayer CropScience will honor Illinois ... Care Community Leadership Award. The award will be announced ... in Washington, D.C., an event where supporters of pollinator ... food supply. , The Bayer Bee Care Community ... of the honey bee colony to benefit their community. ...
(Date:6/19/2013)... , June 19, 2013 ... Book Bureau presents Innovative Drug ... Formulation Technology Licensing Opportunities for ... ) There are ... controlled release drugs approved all ...
(Date:6/19/2013)... Applied Rigaku Technologies, Inc. is pleased to ... of sulfur in ultra-low sulfur diesel (ULSD) using the ... analyzer . The analysis detailed in Rigaku Application Note ... This International Standard specifies an energy dispersive X-ray fluorescence ... in automotive gasoline. , Regulations around the world have ...
Breaking Biology Technology:MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2
... 2009 Senomyx, Inc. (Nasdaq: SNMX ), ... discover and develop novel flavor ingredients for the food, ... SA has selected a new flavor ingredient, which was ... for development activities and evaluation of commercial potential in ...
... -- American Oriental,Bioengineering, Inc. (NYSE: AOB ), ... manufacture and commercialization of,a broad range of prescription and ... Company,s participation in the following conferences: , , ... May 6-8 at the Ritz Carlton in, ...
... Breakthrough biotechnology research is providing new applications ... and diabetes, two leading health concerns among consumers. ... Advana Science, www.advanascience.com , will ... this dynamic consumer healthy category at VitaFoods International ...
Cached Biology Technology:SENOMYX ANNOUNCES NESTLE'S SELECTION OF A NEW FLAVOR INGREDIENT FOR EVALUATION OF COMMERCIAL POTENTIAL 2SENOMYX ANNOUNCES NESTLE'S SELECTION OF A NEW FLAVOR INGREDIENT FOR EVALUATION OF COMMERCIAL POTENTIAL 3Industry Expert Reveals Cutting Edge Biotechnology Science for Nutraceutical and Functional Food Applications 2
(Date:6/19/2013)... mammals and birds are threatened with extinction as a result ... colleagues from The Ohio State University in the US. Their ... growth of the human population will continue to pose a ... appear to be a threshold above which population growth would ... published online in Springer,s journal, Human Ecology . , ...
(Date:6/19/2013)... AT&T * and NEC Corporation ... the ultimate workhorse among ruggedized 4G LTE ... the most ruggedized phones equipped with AT&T ... versatility and business-ready features.  Its design is aimed ... forward, while also keeping up with daily life ...
(Date:6/19/2013)... physiological anabolic agent for tissue-building and energy storage, ... and carbohydrates, and inhibiting their breakdown and release ... major role in stimulating glucose entry into muscle ... from the blood following meals. But gaps exist ... insulin regulates glucose uptake in fat and muscle ...
Breaking Biology News(10 mins):Are we pushing animals over the edge? 2AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 2AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 3AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 4AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 5Breakthrough research of essential molecule reveals important targets in diabetes and obesity 2
... laminin, a protein that helps cells stick together, may ... The related report by Rooney et al, "Laminin-111 restores ... integrin congenital myopathy," appears in the January 2009 issue ... Muscular dystrophy is a group of inherited genetic diseases ...
... across, researchers have identified the clockwork that drives ... motor,s strength--to scale, twice that of an automobile--the ... In addition, because a number of virus types ... that causes herpes, the results may also assist ...
... assistant professor of chemistry in Arts & Sciences, ... National Institute of Mental Health for research titled ... Maurer,s long term objective is to ... variety of neuronal wiring processes. He is starting ...
Cached Biology News:Viruses, start your engines! 2Viruses, start your engines! 3Chemist receives NIH funding to unravel tricks of neuronal wiring 2
... from non-demolished blood that is ... The donors are not medicated ... maintained on an antibiotic free ... : 85 mg/ml (by Refractometry).Strain: ...
Alkaline Phosphatase (E. coli C75), 100 units. Removes 5'-phosphates from DNA. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Alkaline Phosphatases....
... CyScribe First-Strand cDNA Labeling Kit ... reactions. For the generation and purification ... are packaged together for complete cDNA ... can be used for performing labeling ...
... CyScribe Post-Labeling Kit with CyScribe ... the generation and purification of Cy3- ... together for complete cDNA labeling and ... used for performing labeling reactions with ...
Biology Products: